Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
HAMILTON, Bermuda, June 04, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 8:40 a.m. Eastern Time.
百慕大哈密尔顿，2024年6月4日（全球新闻社）— kiniksa pharmaceuticals有限公司。（纳斯达克：KNSA）今天宣布，公司管理层将参加高盛45的观摩会议。thKiniksa的演讲将在公司网站的投资者和媒体版块上通过直播网络传输。大会回顾也将在演讲后约48小时内在Kiniksa的网站上提供。
A live webcast of Kiniksa's presentation will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.
Kiniksa的演示现场网络直播可通过公司网站的投资者和媒体板块 &（www.kiniksa.com）访问。www.kiniksa.com是再生元制药公司的注册商标。该活动的重播也将在活动结束后约48小时内在Kiniksa的网站上提供。
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's immune-modulating assets, ARCALYST, abiprubart, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
ARCALYST是再生元制药公司的注册商标。
Kiniksa是一家商业化阶段的生物制药公司，专注于发现、收购、开发和商业化治疗那些患有严重未满足医疗需求的疾病患者的治疗药物。Kiniksa的免疫调节资产，ARCALYST阿比普鲁巴特（abiprubart）和马夫利姆单抗（mavrilimumab）基于强有力的生物学原理或经过验证的机制，针对一系列未得到满足的心血管和自身免疫疾病，并提供差异化潜力。欲了解更多信息，请访问（www.kiniksa.com）。www.kiniksa.com是再生元制药公司的注册商标。.
ARCALYST is a registered trademark of Regeneron Pharmaceuticals, Inc.
ARCALYST再生元制药公司的注册商标。
Every Second Counts!
Kiniksa Investor and Media Contact
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com
每一秒都尤为重要！
Kiniksa投资者和媒体联系人
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com